Mdxhealth, Inc.
Irvine, CA
- UEI
- LQGYDJJ9K8Q6
- CAGE
- 7F2H8
- Primary NAICS
- 621511 Medical Laboratories
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
-
- 621511 Medical Laboratories Primary
- Corporate family
-
-
Mdxhealth, Inc.
LQGYDJJ9K8Q6
- Exosome Diagnostics Inc. TCKUCULVVY39
-
Mdxhealth, Inc.
LQGYDJJ9K8Q6
- SAM.gov registration date
- Physical address
- 15279 Alton Pkwy #100, Irvine, CA 92618, USA
- Website
- mdxhealth.com
- Founded
- 2004
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- Health Care Services
- SIC code
- 80 Health Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Do prostate cancer test- do option 4 | Veterans Integrated Service Network 8 | $62,668 | |
| Mdxhealth GPS | Veterans Integrated Service Network 17 | $15,965 | |
| DX prostate testing | Veterans Integrated Service Network 17 | $27,658 | |
| DX prostate testing | Veterans Integrated Service Network 17 | $0 | |
| MDX health testing for VISN 19 | Veterans Integrated Service Network 19 | $243,669 |
About Mdxhealth, Inc.
Mdxhealth, Inc. is a for-profit healthcare company headquartered in Irvine, California, specializing in molecular diagnostic services for cancer testing and analysis. The company is registered in SAM.gov and maintains an active federal contracting presence as a prime contractor with the U.S. Department of Veterans Affairs. Mdxhealth provides advanced genomic and epigenetic testing services to support personalized diagnosis and treatment strategies for veterans across the VA's national healthcare system, leveraging proprietary technologies and biomarker analysis to deliver specialized cancer screening capabilities.
Mdxhealth has demonstrated sustained federal contracting activity with the Department of Veterans Affairs across multiple Veterans Integrated Service Networks, providing a range of specialized cancer diagnostic testing services through various blanket purchase agreement calls and delivery orders. The company's primary service offerings include Oncotype DX prostate testing, DX prostate testing, Genomic Prostate Score (GPS) testing, MDX Health Testing, and other advanced molecular diagnostic services for prostate, lung, and colorectal cancers. All identified contract awards to Mdxhealth have been issued by the VA through various VISNs, including VISN 5, VISN 8, VISN 10, VISN 17, VISN 19, and VISN 21, with funding flowing through the Department of Veterans Affairs' Veterans Health Administration. These contracts have been awarded under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II), a General Services Administration vehicle that enables streamlined procurement of laboratory services. Contract awards have ranged in value from approximately $3,000 to $1.22 million for individual calls and delivery orders, with services performed at Mdxhealth's primary facility in Irvine, California and secondary locations in Mather, California, Temple, Texas, and Aurora, Colorado. None of the identified contract awards contain small business set-aside designations, indicating Mdxhealth competes as a standard commercial vendor in open market procurements.
Mdxhealth currently holds six active Blanket Purchase Agreements serving as indefinite delivery vehicles with the Department of Veterans Affairs. The largest IDV is a $4.8 million BPA awarded by VISN 17 on May 1, 2023, extending through April 30, 2028, for Oncotype DX prostate testing services under the FSS-621-II schedule. A second substantial vehicle is the $1.424 million BPA awarded by VISN 19 on October 1, 2025, with a five-year performance period through September 30, 2030, for MDX Health Testing services. Additional BPA vehicles include a $480,000 agreement with VISN 17 for DX Prostate Testing through January 9, 2030; a $280,000 BPA with VISN 17 for DX Prostate Testing services through April 2, 2029; a $240,000 vehicle with VISN 17 for MDXHEALTH GPS services through June 4, 2028; and a $755,655 BPA with VISN 8 for prostate cancer testing services through June 30, 2027, which notably carries a total small business set-aside designation. All BPA vehicles are single-award contracts issued under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule and do not include geographic or socioeconomic restrictions beyond the VISN 8 contract's small business designation, enabling Mdxhealth to efficiently deliver specialized cancer diagnostic capabilities across the VA's integrated service network structure.
Contract vehicles
Quick answers
What is Mdxhealth, Inc.'s UEI?
Mdxhealth, Inc.'s Unique Entity ID (UEI) in SAM.gov is LQGYDJJ9K8Q6.
What is Mdxhealth, Inc.'s CAGE code?
Mdxhealth, Inc.'s CAGE code is 7F2H8.
What is Mdxhealth, Inc.'s primary NAICS code?
Mdxhealth, Inc.'s primary NAICS code is 621511 (Medical Laboratories).
Where is Mdxhealth, Inc. located?
Mdxhealth, Inc.'s physical address in SAM.gov is 15279 Alton Pkwy #100, Irvine, CA 92618, USA.
Is Mdxhealth, Inc. registered in SAM.gov?
Yes. Mdxhealth, Inc.'s SAM.gov registration is active through August 25, 2027.
Which contract vehicles does Mdxhealth, Inc. hold?
Mdxhealth, Inc. holds a place on 1 federal contract vehicle: FSS-621-II.
What is Mdxhealth, Inc.'s most recent federal award?
Mdxhealth, Inc.'s most recent federal contract award is Do prostate cancer test- do option 4 (36C24826N0634), from Veterans Integrated Service Network 8, on July 10, 2026.
On GovTribe
See Mdxhealth, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors